Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 31% ± 20% | |
lung | 14 studies | 25% ± 8% | |
peripheral blood | 12 studies | 22% ± 5% | |
eye | 6 studies | 26% ± 11% | |
bone marrow | 4 studies | 19% ± 2% | |
heart | 4 studies | 21% ± 1% | |
kidney | 4 studies | 19% ± 1% | |
liver | 4 studies | 26% ± 9% | |
adipose | 4 studies | 30% ± 6% | |
intestine | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 10525.40 | 459 / 459 | 100% | 76.98 | 1118 / 1118 |
esophagus | 100% | 10702.11 | 1445 / 1445 | 100% | 69.79 | 183 / 183 |
intestine | 100% | 10237.55 | 966 / 966 | 100% | 67.82 | 527 / 527 |
ovary | 100% | 10274.82 | 180 / 180 | 100% | 44.08 | 430 / 430 |
prostate | 100% | 7711.35 | 245 / 245 | 100% | 63.66 | 502 / 502 |
stomach | 100% | 7620.89 | 359 / 359 | 100% | 66.26 | 286 / 286 |
lung | 100% | 10564.77 | 578 / 578 | 100% | 49.62 | 1154 / 1155 |
bladder | 100% | 8629.76 | 21 / 21 | 100% | 56.58 | 503 / 504 |
uterus | 100% | 11561.49 | 170 / 170 | 100% | 50.89 | 457 / 459 |
thymus | 100% | 8046.23 | 653 / 653 | 100% | 60.42 | 602 / 605 |
kidney | 100% | 6689.62 | 89 / 89 | 99% | 46.85 | 896 / 901 |
skin | 100% | 11774.57 | 1809 / 1809 | 99% | 56.26 | 468 / 472 |
adrenal gland | 100% | 8486.00 | 258 / 258 | 99% | 38.42 | 227 / 230 |
brain | 98% | 5193.15 | 2602 / 2642 | 100% | 43.13 | 705 / 705 |
pancreas | 98% | 4063.27 | 323 / 328 | 99% | 57.10 | 177 / 178 |
liver | 100% | 3861.13 | 225 / 226 | 98% | 31.35 | 397 / 406 |
adipose | 100% | 10766.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10773.95 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.80 | 29 / 29 |
spleen | 100% | 9475.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.64 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.19 | 1 / 1 |
muscle | 100% | 6099.73 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 5809.39 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 5652.59 | 882 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 22.90 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0045199 | Biological process | maintenance of epithelial cell apical/basal polarity |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0046755 | Biological process | viral budding |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0016236 | Biological process | macroautophagy |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0061952 | Biological process | midbody abscission |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0090559 | Biological process | regulation of membrane permeability |
GO_0097734 | Biological process | extracellular exosome biogenesis |
GO_0006997 | Biological process | nucleus organization |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0015031 | Biological process | protein transport |
GO_0000915 | Biological process | actomyosin contractile ring assembly |
GO_0090611 | Biological process | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway |
GO_1903553 | Biological process | positive regulation of extracellular exosome assembly |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_1903551 | Biological process | regulation of extracellular exosome assembly |
GO_0001772 | Cellular component | immunological synapse |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0070971 | Cellular component | endoplasmic reticulum exit site |
GO_0005925 | Cellular component | focal adhesion |
GO_0090543 | Cellular component | Flemming body |
GO_0005829 | Cellular component | cytosol |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0042641 | Cellular component | actomyosin |
GO_0005768 | Cellular component | endosome |
GO_0042470 | Cellular component | melanosome |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0031871 | Molecular function | proteinase activated receptor binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PDCD6IP |
Protein name | Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95) Programmed cell death 6 interacting protein |
Synonyms | KIAA1375 ALIX AIP1 |
Description | FUNCTION: Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes . The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis . Adapter for a subset of ESCRT-III proteins, such as CHMP4, to function at distinct membranes. Required for completion of cytokinesis . May play a role in the regulation of both apoptosis and cell proliferation. Regulates exosome biogenesis in concert with SDC1/4 and SDCBP . By interacting with F-actin, PARD3 and TJP1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier (By similarity). .; FUNCTION: (Microbial infection) Involved in HIV-1 virus budding. Can replace TSG101 it its role of supporting HIV-1 release; this function requires the interaction with CHMP4B. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as enveloped virus budding (HIV-1 and other lentiviruses). . |
Accessions | ENST00000457054.6 [Q8WUM4-2] Q8WUM4 ENST00000430877.5 F8WEQ7 ENST00000307296.8 [Q8WUM4-1] ENST00000648706.1 A0A3B3IT07 F8WBR8 F8WDK9 C9IZF9 ENST00000435909.5 ENST00000413073.1 ENST00000412887.5 |